AnalytiCon Discovery, GmbH


Logo

Company Logo - AnalytiCon Discovery, GmbH


Contact Data

Phone number: 49-331-2300-300
Fax number: 49-331-2300-333
More information: MolPort & AnalytiCon webinar on AnalytiCon's unique chemical space
Address line 1: Hermannswerder Haus 17
Address line 2:
City: Potsdam
State/Province/Region:
Zip/Postal code: 14473
Country: Germany
Web page: http://www.ac-discovery.com


Notes

AnalytiCon Discovery GmbH is a biotechnology company focusing on the development of compound libraries consisting of natural product and synthetic small molecules. Database contains more than 25,000 pure natural product small molecules, with over 40% of them representing novel structures.



Compounds

First Previous Previous 1 2 3 4 5 6 Next Next Last

# Catalog Number IUPAC
1. FRG-00279 (6R)-4-benzyl-1,4-oxazepan-6-ol
2. FRG-00284 ethyl 2-(N-benzyl-1-cyclopropylformamido)acetate
3. FRG-00285 ethyl 4-(furan-2-carbonyl)piperazine-1-carboxylate
4. FRG-00286 1-benzyl-4-(furan-2-carbonyl)piperazine
5. FRG-00287 1-(furan-2-carbonyl)-4-(pyridin-2-yl)piperazine
6. FRG-00288 1-(4-benzylpiperazin-1-yl)-2,2-dimethylpropan-1-one
7. FRG-00290 (2E)-3-phenyl-1-[4-(pyridin-2-yl)piperazin-1-yl]prop-2-en-1-one
8. FRG-00291 1-(2-methylbenzoyl)-4-(pyridin-2-yl)piperazine
9. FRG-00292 1-cyclopentanecarbonyl-4-(pyridin-2-yl)piperazine
10. NP-023117 (1R,3bR,7R,8S,9aS,11aS)-1-ethyl-7,8-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-2-one
11. NP-023116 (1R,2S,3S,5S,11R,12R)-5-(furan-3-yl)-12-hydroxy-3,11-dimethyl-6,14-dioxatetracyclo[10.2.2.0²,¹¹.0³,⁸]hexadeca-8,15-diene-7,13-dione
12. NP-000479 10-hydroxy-1,6-dimethyl-9-(propan-2-yl)-5,12-dioxatricyclo[9.1.0.0⁴,⁶]dodecan-8-yl (2E)-3-phenylprop-2-enoate
13. NP-023119 4-{2-[(8aR)-4-hydroxy-2,5,5,8a-tetramethyl-3-oxo-3,5,6,7,8,8a-hexahydronaphthalen-1-yl]ethyl}-5-hydroxy-2,5-dihydrofuran-2-one
14. NP-023118 (1R,5S,6R,10R,11S,12R,15R,16R,18S)-18-(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadec-8-en-16-yl propanoate
15. NP-003504 5,11,17,19-tetrahydroxy-15-methyl-2-oxapentacyclo[9.8.0.0¹,³.0⁴,⁹.0¹²,¹⁷]nonadeca-4,6,8-triene-10,13-dione
16. NP-012462 2-[(2R,2'R,6'S,7'R,8'aS)-4,6',7'-trihydroxy-2',5',5',8'a-tetramethyl-6-oxo-3,3',4',4'a,5',6,6',7,7',8,8',8'a-dodecahydro-2'H-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-7-yl]-3-methylpentanoic acid
17. NP-013794 (2S,3R,4S,5S,6R)-2-(4-hydroxy-3-methoxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
18. NP-016820 7-{[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4H-chromen-4-one
19. NP-012466 N-(5-acetamidopentyl)acetamide
20. NP-016828 (6E,10E)-12-(2,6-dihydroxy-4-methylphenyl)-2,6,10-trimethyl-4-oxododeca-6,10-dien-5-yl acetate
21. NP-016829 2-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-1,3-dimethoxy-5-methylbenzene
22. NP-020080 {3-hydroxy-7,14-dimethoxy-17-methyl-5-oxo-12,16,21-trioxapentacyclo[15.3.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]henicosa-2(15),3,6,8,10,13-hexaen-8-yl}oxidanesulfonic acid
23. NP-024440 (2,3-dihydroxypropoxy)({2-hydroxy-3-[(14-methylpentadecanoyl)oxy]propoxy})phosphinic acid
24. NP-020084 (2Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid
25. NP-003502 methyl (1S,2R,4R,8R,9S,10R,13R,15R)-2-(acetyloxy)-13-(furan-3-yl)-9-(2-methoxy-2-oxoethyl)-4,8,10,12-tetramethyl-7-oxo-16-oxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-5,11-diene-4-carboxylate
26. NP-004833 1-acetyl-1,3a,3b-trihydroxy-7-{[5-({5-[(3-hydroxy-4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-4-methoxy-6-methyloxan-2-yl}oxy)-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-11-yl benzoate
27. NP-023111 (6S)-3,6-dihydroxy-2-[(11Z)-octadec-11-enoyl]cyclohex-2-en-1-one
28. NP-003501 (4aS)-6,7-dihydroxy-1,1,4a-trimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-9-one
29. NP-023110 (6S)-2-[9-(2H-1,3-benzodioxol-5-yl)nonanoyl]-3,6-dihydroxycyclohex-2-en-1-one
30. NP-000476 (2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4aR,5R,6aS,6bR,10R,12aR)-10-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
31. NP-023112 (6S)-2-[11-(2H-1,3-benzodioxol-5-yl)undecanoyl]-3,6-dihydroxycyclohex-2-en-1-one
32. NP-020089 (1S,3R,4S,12R,14S,17S,20S)-4,8,8,12-tetramethyl-17-(2-methylpropyl)-13,15,18-triazaheptacyclo[11.8.6.0¹,¹⁴.0³,¹².0⁴,⁹.0¹⁵,²⁰.0²²,²⁷]heptacosa-22,24,26-triene-16,19-dione
33. NP-023115 (1S,4S,5R,9S,10R,13R,14R)-5-[(acetyloxy)methyl]-9-methyl-14-{[(2-methylpropanoyl)oxy]methyl}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
34. NP-000474 (2S,3S,4R,5R,6R)-6-{[(3R,6aR,6bS,8R,8aR,14bR)-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-8a-({[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}-4,5-dihydroxy-3-{[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}oxane-2-carboxylic acid
35. NP-023114 (1S,4S,5R,9S,10R,13R,14R)-5-(hydroxymethyl)-9-methyl-14-{[(2-methylpropanoyl)oxy]methyl}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
36. NP-024437 2-(2-{[2-(2-hydroxy-4-methylpentanamido)-3-methylbutanoyl]oxy}-3-methylbutanamido)-4-methylpentanoic acid
37. NP-023105 (1S,4S,5R,9S,10R,13R,14R)-5,14-bis(hydroxymethyl)-9-methyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
38. NP-023108 4-methoxy-3-(3-methylbut-2-en-1-yl)-1,2-dihydroquinolin-2-one
39. NP-024439 (2,3-dihydroxypropoxy)({2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propoxy})phosphinic acid
40. NP-023107 (2S,3R,4S,5S,6R)-2-{[(5E)-2-hydroxy-2,6-dimethylocta-5,7-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
41. NP-024438 {2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propoxy}(2-hydroxy-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propoxy)phosphinic acid
42. NP-019087 (2S,3R,4S,5S)-3-{[(2S,3R,4S,5R,6S)-5-{[(2S,3R,4S,5R)-4-{[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl (4aR,5R,6aS,6bR,9R,10R,11S,12aR,14bS)-5,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
43. NP-019088 (2S,3R,4S,5S)-3-{[(2S,3R,4S,5R,6S)-5-{[(2S,3R,4S,5R)-4-{[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl (4aR,5R,6aS,6bR,10R,11S,12aR,14bS)-10-{[(2R,3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5,11-dihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
44. NP-023109 (6S)-2-[7-(2H-1,3-benzodioxol-5-yl)heptanoyl]-3,6-dihydroxycyclohex-2-en-1-one
45. NP-003517 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-(3-methylbut-2-en-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one
46. NP-019085 (2S,3R,4S,5S)-3-{[(2S,3R,4S,5R,6S)-5-{[(2S,3R,4S,5R)-4-{[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl (4aR,5R,6aS,6bR,10R,11S,12aR,14bS)-5,11-dihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-10-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
47. NP-019086 (2S,3R,4S,5S)-3-{[(2S,3R,4S,5R,6S)-5-{[(2S,3R,4S,5R)-4-{[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl (4aR,5R,6aS,6bR,10R,11S,12aR,14bS)-5,11-dihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-10-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
48. NP-013783 [2-({3-hydroxy-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphonato}oxy)ethyl]trimethylazanium
49. NP-013780 3-(3,4,5-trimethoxyphenyl)propanoic acid
50. NP-012454 (4aR,5R,6aS,6bR,10S,12aR)-10-{[(2R,3R,4R,5S,6R)-6-({[(2S,3R,4S,5S)-4,5-dihydroxy-3-{[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-3-acetamido-4,5-dihydroxyoxan-2-yl]oxy}-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid

First Previous Previous 1 2 3 4 5 6 Next Next Last

 
2021 MolPort, v4.15, release date 18-01-2021 14:00 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.